Schedule 13E-3

Schedule 13E-3

A form that a company must file with the SEC during a management buyout. That is, the schedule 13E-3 is filed when the senior management of a publicly-traded company buys all of the company's shares outstanding. A schedule 13E-3 is necessary because it stops trade on the company's stock and allows the company to operate without recourse to shareholders.

Schedule 13E-3

An SEC form that must be filed when a company is taken private. See also going private.
Mentioned in ?
References in periodicals archive ?
In connection with the proposed merger, the company has filed a transaction statement on Schedule 13E-3, a preliminary proxy statement and related materials with the Securities and Exchange Commission, and expects to file an amendment to the Schedule 13E-3 and updated proxy materials with the SEC in a timely manner.
The plan has been approved by the Cimetrix board of directors and is fully disclosed in the SEC Schedule 13E-3 filing, which is available at www.
In connection with the transaction, the Company intends to file an information statement and other relevant materials with the SEC, and the Company and certain other persons intend to file a Schedule 13E-3 transaction statement with the SEC.
This information amends the previously filed Schedule 13E-3 Transaction Statement by the group taking the company private through a short form merger.
OTCQB: HXBM) (the "Company"), a developer of bioactive peptides, today announced that it has filed a Schedule 13E-3 and related preliminary proxy statement with the Securities and Exchange Commission (the "SEC") in connection with a proposed transaction that is intended to result in the suspension of the Company's public reporting obligations under the Securities and Exchange Act of 1934 (the "Exchange Act").
Shenzhen-based pharmaceutical company Tongjitang Chinese Medicines Company (NYSE:TCM) revealed on Monday that it has filed a going-private transaction statement on Schedule 13E-3 with the US Securities and Exchange Commission (SEC) on the basis of the proposed merger agreement between the company and Fosun Industrial Co Ltd, Hanmax Investment Ltd and Tonsun International Company Ltd.
The company has filed with the US Securities and Exchange Commission (SEC) a Schedule 13E-3 transaction statement and a related preliminary redemption notice/transaction statement.
ATLANTA -- Atlanta-based ASSURANCEAMERICA CORPORATION (the "Company") announced today that it is again postponing for at least sixty (60) days the 10,000-to-one reverse stock split (the "Reverse Stock Split") of the Company's common stock (the "Common Stock") described in the Schedule 13E-3 Transaction Statement filed by the Company with the Securities and Exchange Commission on November 4, 2011 and amended by Amendment No.
Making this announcement on Wednesday, the company said that it intends to file a Schedule 13E-3 with respect to the proposed offer with the US Securities and Exchange Commission and submit the necessary court filings to the Courts of the British Virgin Islands with respect to the proposed offer as soon as possible.
1% of Digital Lightwave's outstanding shares filed a Schedule 13E-3, concerning the merger, with the US Securities and Exchange Commission on Wednesday.
Limited partners of the Public Partnerships may obtain free copies of the applicable Definitive Proxy Statement and Schedule 13E-3 (and any other related materials when they become available) as well as other filed documents containing information about the Public Partnerships at http://www.
A preliminary proxy statement and Schedule 13E-3 will soon be filed with the US Securities and Exchange Commission (SEC) to initiate the reverse/forward stock split.